FDA's Woodcock To Testify At Adverse Drug Events Hearing Feb. 1
FDA Center for Drug Evaluation & Research Director Janet Woodcock, MD, will testify before a Senate Health, Education, Labor & Pensions Committee hearing on adverse drug events Feb. 1.
FDA Center for Drug Evaluation & Research Director Janet Woodcock, MD, will testify before a Senate Health, Education, Labor & Pensions Committee hearing on adverse drug events Feb. 1.